Clinical & Diagnostic
FDA Approves PENBRAYA™: First Vaccine for 5 Common Meningococcal Serogroups in Teens
PENBRAYA™ provides the broadest serogroup coverage (meningococcal groups A, B, C, W and Y) of any meningococcal vaccine available in the U.S. ...
October 23, 2023 | News
Thermo Fisher & Boehringer Ingelheim Join Forces for NSCLC Companion Diagnostics in Japan and the US
To support emerging precision therapies and improve patient outcomes by increasing access to reliable genomic testing needed to match patients with targete...
October 20, 2023 | News
NUS Scientists Create Magnetic Gel Speeding Up Diabetic Wound Healing 3x
Diabetic patients, whose natural wound-healing capabilities are compromised, often develop chronic wounds that are slow to heal. Such non-healing wounds co...
October 20, 2023 | News
SOPHiA GENETICS Partners with MSKCC and AstraZeneca for Global Cancer Care Equality
SOPHiA GENETICS (Nasdaq: SOPH), a category-defining software company and a global leader in data-driven medicine today announced a collaboration with&...
October 19, 2023 | News
CANbridge Reaches Full Enrollment in Phase 2 Trial for Gaucher Disease in China
Phase 2 is a randomized, double-blind, dose comparison study to evaluate the efficacy, safety and pharmacokinetics of CAN103 in newly treated GD patients, ...
October 17, 2023 | News
TaiMed Reports Major Advances in Clinical Trials for New HIV Treatment in Taiwan
TaiMed Biologics, an innovation-driven biotech company dedicated to serving unmet healthcare needs, has announced favorable results and the successful comp...
October 17, 2023 | News
Adalvo and Eurolab strengthen Strategic Partnership in South Africa and SSA Regions
These value-added products encompass a diverse range of segments, each catering to specific indications and fulfilling unique patient needs. The portfolio ...
October 16, 2023 | News
AbbVie's SKYRIZI® Outperforms STELARA® in Crohn's Disease Study
SEQUENCE, a Phase 3 head-to-head study, compared risankizumab to ustekinumab for the treatment of adult patients with moderately to severely active ...
October 16, 2023 | News
Ascentage Pharma & AstraZeneca Collaborate on Phase III Study for CLL/SLL Treatment
The two companies will jointly conduct a registrational Phase III study of the Bcl-2 inhibitor, APG-2575 (lisaftoclax), in combination with AstraZeneca's B...
October 16, 2023 | News
Nona Biosciences and INGENIA Therapeutics Join Forces for Immunology Breakthroughs
By harnessing the immense expertise and resources of both companies, the collaboration aims to accelerate the development of innovative therapeutics for im...
October 16, 2023 | News
CARsgen's CAR-GPC3 T-cell Therapy for Advanced Hepatocellular Carcinoma
CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignan...
October 13, 2023 | News
Metabolon Introduces Liver and Kidney Panels for Disease Research
Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic developme...
October 13, 2023 | News
MediLink and BioNTech Partner for Advanced Anti-Cancer Drug
Under the terms of the agreement, MediLink will grant BioNTech exclusive global rights for the development, manufacturing, and commercialization of one of ...
October 13, 2023 | News
EQT's Acquisition: VetPartners, Key Animal Health Provider in Australia and New Zealand
EQT to acquire VetPartners, the leading provider of veterinary and animal health services across a network of 267 general practice clinics and specialty ...
October 12, 2023 | News
Most Read
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2025
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
- James Park Joins South Korean LOTTE BIOLOGICS as New CEO to Lead Global Expansion
- Australia Takes the Lead: Moderna Opens Southern Hemisphere’s First mRNA Manufacturing Facility in Victoria
- Eli Lilly Announces $3 Billion Expansion in Wisconsin to Boost Global Medicine Production
- Ngee Ann Polytechnic Partners with Merck Singapore to Elevate Biopharmaceutical Education
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Life Sciences CEOs Bet Big on AI and Workforce Growth Despite Economic and Industry Headwinds
News
